from Reuters: Health News https://ift.tt/2OtssYL
Wednesday, August 15, 2018
Wednesday, August 15, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Amicus Therapeutics on Monday set an average price of $315,000 per year for its newly approved Fabry disease treatment, a price it believes is below that of the main existing treatment in the United States.

from Reuters: Health News https://ift.tt/2OtssYL
from Reuters: Health News https://ift.tt/2OtssYL
Related Posts:
LATEST HEALTH NEWSExpress Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after pric… Read More
LATEST HEALTH NEWSThe Ebola outbreak in Democratic Republic of Congo is likely to worsen significantly unless the response to it is stepped up, an emergency committee of experts convened by the World Health Organization said on Wednesday. … Read More
LATEST HEALTH NEWS(Reuters Health) - An HIV-prevention drug pill, dubbed PrEP, dramatically reduced new infections in a large group of high risk gay men, Australian researchers report. from Reuters: Health News https://ift.tt/2RWwknB … Read More
LATEST HEALTH NEWS(Reuters Health) - New mothers who want intrauterine devices (IUDs) for long-acting contraception after giving birth should know the risk of the implant being expelled is tied to how soon after delivery it is inserted, resear… Read More
LATEST HEALTH NEWS(Reuters Health) - For people with diabetes, the chance of developing eye damage that can lead to blindness may depend on how many hours per day they can keep their blood sugar levels under control, a Chinese study suggests. … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment